Racial and ethnic differences in capecitabine toxicity in patients with gastrointestinal tract cancers

BACKGROUND: Capecitabine is used as a first-line treatment for gastrointestinal (GI) tract cancers. Common toxicities of capecitabine include diarrhea and hand-foot syndrome, which frequently require dose reduction, interruption, or discontinuation. While racial and ethnic differences in capecitabin...

Descripción completa

Detalles Bibliográficos
Autores principales: Brazelton, Alicia, Yande, Soham, Pope, Rita, Johnson, Michael L., Musher, Benjamin, Trivedi, Meghana V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922257/
https://www.ncbi.nlm.nih.gov/pubmed/35479584
http://dx.doi.org/10.20524/aog.2022.0688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922257/
https://www.ncbi.nlm.nih.gov/pubmed/35479584
http://dx.doi.org/10.20524/aog.2022.0688

Ejemplares similares